Skip to main content
Trending storyHistorical stories

Lila Bio wins $3.65M NIH grant for pulmonary hypertension

1 reports1 report sources5 days agoUpdate

Get up to speed on this story

AI Summary

Lila Bio, a startup spun out of David Baker's University of Washington lab, has received a $3.65 million NIH grant to develop a protein-based treatment for pulmonary hypertension. The first $605,981 funds early testing in mice, rats and non-human primates. A second phase of $3,049,462 covers further animal testing and studies using patient lung tissue.

AI-generated from reports · 5 days agoUpdate

Report timeline

Follow the reports to understand different sides of the story.

Nov 12
  1. GeekWire
    Lila Bio Lands $3.65M NIH Grant to Fight Pulmonary Hypertension With AI-Designed Proteins

    Lila Bio, a startup spun out of David Baker's University of Washington lab.

Trend for this story

Comparable range current
3
Comparable range peak
10Nov 12 08:00
Change in the last 24 hours
-51%

Trends only compare the same entities observed consistently and completely, so the scope may be smaller than the current trending statistics. Move the pointer or click the chart to view hourly trending; use the left and right arrow keys on a keyboard to switch.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing